Financial Performance - The company's operating revenue for 2024 was ¥605,376,475.82, a decrease of 8.03% compared to ¥658,214,081.40 in 2023[23]. - The net profit attributable to shareholders for 2024 increased by 31.44% to ¥19,365,723.28 from ¥14,733,064.67 in 2023[23]. - The net profit after deducting non-recurring gains and losses was ¥16,258,773.02, up 35.23% from ¥12,022,861.12 in the previous year[23]. - The net cash flow from operating activities decreased by 46.53% to ¥44,186,925.51 from ¥82,635,703.18 in 2023[23]. - Basic earnings per share for 2024 were ¥0.0346, reflecting a 29.59% increase from ¥0.0267 in 2023[23]. - Total assets at the end of 2024 were ¥1,673,622,883.87, a slight increase of 0.21% from ¥1,670,120,180.70 at the end of 2023[23]. - The net assets attributable to shareholders increased by 2.63% to ¥1,505,354,221.40 from ¥1,466,727,453.81 in 2023[23]. - The company reported a significant decline in cash flow from operations in the second quarter, with a net cash flow of -¥123,144,926.86[26]. - The fourth quarter net profit attributable to shareholders was ¥5,672,112.51, showing a recovery from the lower profits in the third quarter[25]. - The company reported government subsidies of approximately ¥3,295.16 million in 2024, a slight increase from ¥3,231.29 million in 2023 and up from ¥2,972.47 million in 2022, indicating a consistent support from government policies[29]. Market and Industry Position - The company operates in the fine chemical industry, with a focus on high-end intermediates, maintaining leading positions in production capacity, output, and sales in various intermediate segments[32]. - The company is focusing on expanding its market presence in the dye and chemical intermediate sectors, driven by the recovery in textile and cosmetic industries, despite some short-term challenges[35]. - The company is adapting to regulatory changes in the pharmaceutical and pesticide sectors, which are expected to guide major enterprises towards growth and efficiency improvements[39]. - The company anticipates significant growth in sales of new color developers like JX201 in 2024, driven by stricter standards on bisphenol A in thermal paper, which will create new market opportunities[41]. - The company has maintained a high global market share despite increased competition and a decline in average product prices due to rapid supply growth[44]. - The company is actively expanding its customer base and sales channels to increase revenue and improve capacity utilization[44]. Research and Development - The company achieved a research and development investment of 35.67 million yuan, accounting for 5.89% of its operating revenue[58]. - The company is focusing on technological innovation and new product development in fields such as new materials and electronic chemicals to enhance its competitive edge[44]. - The company has completed several R&D projects, including the development of new production processes aimed at improving product yield and reducing environmental impact[75]. - The company has established a stable management team and core talent, with 7 high-end talents recruited in 2024, including 3 master's degree holders[60]. - The company has implemented three stock incentive plans to align the personal goals of core management and technical personnel with the long-term development of the company[61]. Environmental and Safety Compliance - The company has implemented a complete safety production system to reduce safety risks associated with the use of flammable and explosive chemicals[6]. - The company has invested in upgrading its fire safety systems and has completed the construction of 15 modules for its safety information management platform[176]. - The company has successfully maintained compliance with environmental regulations across all monitored emission points[169]. - The company received a national pollutant discharge permit valid from July 12, 2024, to July 11, 2029, with specific emission limits for SO2 (9.225t/a), NOx (29.35943t/a), COD (28.974t/a), and ammonia nitrogen (3.653t/a)[168]. - The company has established a comprehensive monitoring frequency for unorganized waste gas emissions and noise levels as part of its self-monitoring plan[170]. Talent and Management - The company acknowledges the risk of talent shortages impacting future development and plans to establish a comprehensive talent cultivation and innovation incentive mechanism[5]. - The company has established a performance evaluation and incentive system linked to business performance, aiming to attract and retain high-quality talent[111]. - The company has implemented a salary management system that adjusts compensation based on job risk, responsibility, and technical requirements, ensuring internal fairness and external competitiveness[141]. - The company has a stable core technical team and maintains a competitive advantage in product structure, innovation capability, and market marketing[48]. - The company has established a comprehensive training system, conducting at least four safety training sessions annually for middle management and above, enhancing employee skills and management capabilities[142]. Financial Management and Governance - The company has a clear profit distribution policy, with 100% of the profit distribution amount allocated to cash dividends in the current period[144]. - The company’s profit distribution plan aligns with its articles of association and shareholder resolutions, ensuring transparency and compliance[143]. - The company has a governance structure that complies with the Company Law and Articles of Association, ensuring independent operation of the board and management[114]. - The company has established specialized committees under the board of directors to enhance decision-making efficiency[158]. - The company has implemented a comprehensive internal control system in accordance with relevant laws and regulations, ensuring effective governance structures among shareholders, the board of directors, and management[158]. Future Outlook and Strategic Goals - The company aims to enhance its R&D capabilities and product competitiveness to mitigate market risks from overseas energy price fluctuations and high inflation[3]. - The company will continue to focus on expanding both domestic and international markets to enhance its market share and profitability[3]. - The company aims to enhance product value and expand its market presence in dye and daily chemical intermediates, composite materials, and pharmaceutical intermediates[100]. - The company plans to invest 200 million RMB in research and development for innovative technologies over the next two years[124]. - The company is exploring investment opportunities in low-altitude economy sectors, including aircraft manufacturing and low-altitude operations, to create new growth points[103].

关于变更年审报告签字会计师的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载，误导性陈述或重大遗漏。 证券代码：300107 证券简称：建新股份 公告编号：2025-001 河北建新化工股份有限公司（以下称"公司"）第六届董事会第六次会议及 2023 年度股东大会审议通过了《关于拟续聘会计师事务所的议案》，同意继续 聘任中审众环会计师事务所（特殊普通合伙）（以下简称"中审众环"）为公司 2024 年度审计机构。《关于拟续聘会计师事务所的公告》（公告编号：2024-015） 详见 2024 年 4 月 25 日公司披露于中国证监会指定的创业板信息披露网站巨潮资 讯网(www.cninfo.com.cn)的公告。 河北建新化工股份有限公司 近日，公司收到中审众环《关于变更年审注册会计师的公函》。现将有关事 项具体公告如下： 一、签字会计师变更情况 中审众环作为公司 2024 年度审计机构，原指派马英强、姚志军作为签字注 册会计师为公司提供审计服务。因工作安排原因，由陈琰替换马英强作为公司 2024 年度审计业务的签字会计师（合伙人），继续完成公司 2024 年度财务报告 审计及内部控 ...

证券代码：300107 证券简称：建新股份 公告编号：2024-047 河北建新化工股份有限公司（以下简称"公司"）于 2024 年 10 月 22 日召 开了第六届董事会第十次会议，审议通过了《关于对全资子公司增资的议案》。 具体内容详见 2024 年 10 月 23 日披露于中国证监会指定的创业板信息披露网站 巨潮资讯网(www.cninfo.com.cn)的《关于对全资子公司增资的公告》（公告编 号：2024-046）。 公司近日办理完成了全资子公司沧州建新瑞祥化学科技有限公司注册资本 工商变更登记手续，并取得了中捷产业园区行政审批局换发的《营业执照》。具 体情况如下： 关于全资子公司完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载，误导性陈述或重大遗漏。 变更前： 注册资本：贰亿伍仟万元整 变更后： 注册资本：叁亿伍仟万元整 二、本次变更后的营业执照登记信息 河北建新化工股份有限公司 一、本次变更情况 成立日期：2018 年 06 月 13 日 1 住所：临港化工园区经四路西、纬三路北 经营范围：一般项目：第三类非药品类易制毒化学品生产；合成材料制造（不 ...

证券代码：300107 证券简称：建新股份 公告编号：2024-046 关于对全资子公司增资的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本次增资情况概述 1、为进一步拓展河北建新化工股份有限公司（以下简称"公司"）业务， 提升综合竞争力，满足项目建设及战略发展的需要，结合公司实际情况，拟以自 有资金人民币 10,000 万元对全资子公司沧州建新瑞祥化学科技有限公司（以下 简称"建新瑞祥"）进行增资。 2、公司董事会审议情况：公司于 2024 年 10 月 22 日召开第六届董事会第十 次会议审议通过了《关于对全资子公司增资的议案》。本次增资事项未超过董事 会审批权限，不需要提交公司股东大会审议批准。 董事会授权公司管理层具体办理修订建新瑞祥《公司章程》、工商变更登记 等事宜。 3、本次增资的资金来源为自有资金，不涉及关联交易，亦不构成《上市公 司重大资产重组管理办法》规定的重大资产重组。 二、本次增资标的的基本情况 1、公司名称：沧州建新瑞祥化学科技有限公司 河北建新化工股份有限公司 4、法定代表人：陈学为 5、注册资本：贰亿伍仟万元整 6、成 ...

证券代码：300107 证券简称：建新股份 公告编号：2024-043 河北建新化工股份有限公司 第六届监事会第九次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下称"公司"）第六届监事会第九次会议于 2024 年 10 月 22 日在公司八楼会议室以现场方式召开。会议通知于 2024 年 10 月 12 日以书面及通讯的方式发出，本次会议应出席监事 3 人，实际出席监事 3 人，会议由公司监事孙维政先生主持。公司全体董事、高级管理人员列席了会议。 本次会议的召集、召开、表决程序符合《中华人民共和国公司法》和《公司章程》 的规定。会议经全体监事表决，通过以下事项： 审议通过《关于公司<2024 年第三季度报告>的议案》 经审核：由公司董事会编制和审核的《2024 年第三季度报告》程序和内容 符合法律、行政法规、中国证监会和深圳证券交易所的规定，报告内容真实、准 确、完整地反映了公司 2024 年第三季度的实际情况，不存在任何虚假记载、误 导性陈述或重大遗漏。 表决结果：同意 3 票，反对 0 票，弃权 0 票，获得通 ...

证券代码：300107 证券简称：建新股份 公告编号：2024-042 河北建新化工股份有限公司 第六届董事会第十次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下称"公司"）第六届董事会十次会议于 2024 年 10 月 22 日在公司八楼会议室以现场结合通讯方式召开。会议通知于 2024 年 10 月 12 日以书面及通讯的方式发出，本次会议应出席董事 9 人，实际出席董 事 9 人，会议由公司董事长朱守琛先生主持。公司全体监事、高级管理人员列席 了会议。本次会议的召集、召开、表决程序符合《中华人民共和国公司法》和《公 司章程》的规定。会议经全体董事表决，通过以下事项： 一、审议通过《关于公司<2024 年第三季度报告>的议案》 1 上市公司利益的情形。本次增资完成后，建新瑞祥注册资本由人民币 25,000 万 元增加至人民币 35,000 万元，公司仍持有其 100%股权。 《关于对全资子公司增资的公告》详见同日披露于中国证监会指定的创业板 上市公司信息披露网站巨潮资讯网(www.cninfo.com.cn)的 ...

Group 1: Financial Performance - The company achieved a total revenue of 321.44 million RMB in the first half of 2024, representing a year-on-year increase of 14.56% [6] - The net profit attributable to shareholders for the same period was 11.94 million RMB, showing a year-on-year growth of 44.48% [6] - The gross profit margin for the first half of 2024 was 12.88%, slightly down from 14.54% in the same period last year [5] Group 2: Investment and Development - The company holds an 18.5% stake in Hebei Jianxin Flying Car Technology Co., with an investment of 2.96 million RMB, making it the second-largest shareholder [2][3] - The company plans to invest several tens of millions of RMB in the development and certification of flying cars over the next three years [5] - The average time for obtaining a model certification from the Civil Aviation Administration of China is estimated to be 3-5 years, depending on various factors [1] Group 3: Market Strategy and Risk - The company has implemented measures for market value management, including maintaining a high dividend rate and committing to no share reduction by major shareholders [2] - Investment risks include potential losses due to low-altitude economic policies, market acceptance, production facility construction, and administrative approvals [5][6] - The company is actively seeking new business opportunities in promising industries while focusing on cost reduction and efficiency improvement [2] Group 4: Future Outlook - The company is set to disclose its third-quarter report for 2024 on October 23, 2024 [2][4] - The strategic plan for the first half of 2024 emphasizes expanding product lines in new materials, electronic chemicals, and pharmaceutical intermediates [2] - The company remains optimistic about the market opportunities in the low-altitude economy, supported by national policies [3]

假记载、误导性陈述或重大遗漏。 证券代码：300107 证券简称：建新股份 公告编号：2024-041 河北建新化工股份有限公司 关于参加 2024 年河北辖区上市公司投资者网上集体接待日暨 2024 年半年报业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 为进一步加强与投资者的互动交流，河北建新化工有限公司(以下简称 "公 司")将参加由河北证监局、河北上市公司协会与深圳市全景网络有限公司联合 举办的"2024 年度河北辖区上市公司投资者网上集体接待日暨 2024 年半年报业 绩说明会活动"，现将相关事项公告如下: 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 (http://rs.p5w.net)，或关注微信公众号：全景财经，或下载全景路演 APP，参与 本次互动交流，活动时间为 2024 年 10 月 15 日(周二)14:00-17:00。 届时公司董事长朱守琛先生，董事、总经理兼董事会秘书陈学为先生、财务 总监高辉女士将在线就公司业绩、公司治理、发展战略、经营状况和可持续发展 等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与! ...

证券代码：300107 证券简称：建新股份 公告编号：2024-040 河北建新化工股份有限公司 2022 年股票期权与限制性股票激励计划之限制性股票第二个归 属期归属结果暨股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 2、本次归属股票上市流通时间：2024 年 9 月 6 日。 3、本次限制性股票归属的激励对象共计 22 人（调整后）。 4、本次限制性股票归属股票来源：公司向激励对象定向发行公司 A 股普通 股。 河北建新化工股份有限公司（以下简称"公司"）于 2024 年 7 月 23 日召开第 六届董事会第八次会议、第六届监事会第七次会议，审议通过了《关于 2022 年 股票期权与限制性股票激励计划之限制性股票第二个归属期归属条件成就的议 案》。近日，公司办理了 2022 年股票期权与限制性股票激励计划之限制性票第 二个归属期归属股份的登记工作，现将相关事项公告如下： 一、2022 年股票期权与限制性股票激励计划简述及已履行的相关审批程序 （一）2022 年股票期权与限制性股票激励计划简述 2022 年 7 月 1 日，公司召 ...

证券代码：300107 证券简称：建新股份 公告编号：2024-039 河北建新化工股份有限公司 关于 2022 年股票期权与限制性股票激励计划 之股票期权第二个行权期采用自主行权的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、公司 2022 年股票期权与限制性股票激励计划股票期权代码：036503，期 权简称：建新 JLC3。 2、本次符合行权条件的 74 名激励对象在第二个行权期可行权 171.65 万份 股票期权，行权价格为 5.374 元/份。 3、本次行权拟采用自主行权模式，实际可行权期限为 2024 年 9 月 6 日至 2025 年 7 月 10 日。 4、本次可行权期权若全部行权，公司股份仍具备上市条件。 河北建新化工股份有限公司（以下简称"公司"）于 2024 年 7 月 23 日召开 的第六届董事会第八次会议、第六届监事会第七次会议，审议通过了《关于 2022 年股票期权与限制性股票激励计划之股票期权第二个行权期行权条件成就的议 案》。根据 2022 年第一次临时股东大会的相关授权，公司董事会将按照相关规定 办 ...